1,819
Views
0
CrossRef citations to date
0
Altmetric
State-of-the-Art Review

Effect of bioelectrical impedance technology on the prognosis of dialysis patients: a meta-analysis of randomized controlled trials

, , , , &
Article: 2203247 | Received 21 Nov 2022, Accepted 11 Apr 2023, Published online: 03 May 2023

References

  • Loutradis C, Sarafidis PA, Ferro CJ, et al. Volume overload in hemodialysis: diagnosis, cardiovascular consequences, and management. Nephrol Dial Transplant. 2021;36(12):1–11.
  • de Jager DJ, Grootendorst DC, Jager KJ, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009;302(16):1782–1789.
  • Devereux RB, de Simone G, Ganau A, et al. Left ventricular hypertrophy and hypertension. Clin Exp Hypertens. 1993;15(6):1025–1032.
  • Schmitt W, Rühs H, Burghaus R, et al. NT-proBNP qualifies as a surrogate for clinical end points in heart failure. Clin Pharmacol Ther. 2021;110(2):498–507.
  • Chazot C, Wabel P, Chamney P, et al. Importance of normohydration for the long-term survival of haemodialysis patients. Nephrol Dial Transplant. 2012;27(6):2404–2410.
  • Loutradis CN, Tsioufis C, Sarafidis PA. The clinical problems of hypertension treatment in hemodialysis patients. Curr Vasc Pharmacol. 2017;16(1):54–60.
  • Gargani L, Volpicelli G. How I do it: lung ultrasound. Cardiovasc Ultrasound. 2014;12:25.
  • Zoccali C, Torino C, Mallamaci F, et al. A randomized multicenter trial on a lung ultrasound–guided treatment strategy in patients on chronic hemodialysis with high cardiovascular risk. Kidney Int. 2021;100(6):1325–1333.
  • Reddan DN, Szczech LA, Hasselblad V, et al. Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial. J Am Soc Nephrol. 2005;16(7):2162–2169.
  • Velasco N, Chamney P, Wabel P, et al. Optimal fluid control can normalize cardiovascular risk markers and limit left ventricular hypertrophy in thrice weekly dialysis patients. Hemodial Int. 2012;16(4):465–472.
  • Jaffrin MY, Morel H. Body fluid volumes measurements by impedance: a review of bioimpedance spectroscopy (BIS) and bioimpedance analysis (BIA) methods. Med Eng Phys. 2008;30(10):1257–1269.
  • Zoccali C, Moissl U, Chazot C, et al. Chronic fluid overload and mortality in ESRD. J Am Soc Nephrol. 2017;28(8):2491–2497.
  • Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev. 2019;10: ED000142.
  • Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.
  • Sommerer C, Felten P, Toernig J, et al. Bioimpedance analysis is not superior to clinical assessment in determining hydration status: a prospective randomized-controlled trial in a Western dialysis population. Hemodial Int. 2021;25(3):380–390.
  • Brimble KS, Ganame J, Margetts P, et al. Impact of bioelectrical Impedance-guided fluid management and vitamin D supplementation on left ventricular mass in patients receiving peritoneal dialysis: a randomized controlled trial. Am J Kidney Dis. 2022;79(6):820–831.
  • Tian N, Yang X, Guo Q, et al. Bioimpedance guided fluid management in peritoneal dialysis: a randomized controlled trial. Clin J Am Soc Nephrol. 2020;15(5):685–694.
  • Paunic Z, Dekleva-Manojlovic M, Markovic-Nikolic N, et al. Active fluid management improves left ventricular function and mechanics in hemodialysis patients: a randomized trial. Nephrol Dial Transplant. 2020;35(Suppl 3):iii1608.
  • Liu L, Sun Y, Chen Y, et al. The effect of BCM guided dry weight assessment on short-term survival in Chinese hemodialysis patients. BMC Nephrol. 2020;21(1):135.
  • Yoon H, Kwon YJ, Shin SJ, et al. Bioimpedance spectroscopy-guided fluid management in peritoneal dialysis patients with residual kidney function: a randomized controlled trial. Nephrology. 2019;24(12):1279–1289.
  • Patel H, Annigeri RA, Kowdle PC, et al. Bioimpedance spectroscopy-guided ultrafiltration normalizes hydration and reduces intradialytic adverse events in hemodialysis patients. Indian J Nephrol. 2019;29(1):1–7.
  • Oh K, Joo KW, Kim DK, et al. Does routine bioimpedance-guided fluid management provide additional benefit to non-anuric peritoneal dialysis patients? Results from COMPASS clinical trial. Perit Dial Int. 2018;38(2):131–138.
  • Siriopol D, Onofriescu M, Voroneanu L, et al. Dry weight assessment by combined ultrasound and bioimpedance monitoring in low cardiovascular risk hemodialysis patients: a randomized controlled trial. Int Urol Nephrol. 2017;49(1):143–153.
  • Tan B, Yu Z, Fang W, et al. Longitudinal bioimpedance vector plots add little value to fluid management of peritoneal dialysis patients. Kidney Int. 2016;89(2):487–497.
  • Huan-Sheng C, Yeong-Chang C, Ming-Hsing H, et al. Application of bioimpedance spectroscopy in Asian dialysis patients (ABISAD-III): a randomized controlled trial for clinical outcomes. Int Urol Nephrol. 2016;48(11):1897–1909.
  • Zhou YL, Liu J, Ma L, et al. Impact of dry weight determined by calf bioimpedance ratio on carotid stiffness and left ventricular hypertrophy in hemodialysis patients. Artif Organs. 2014;38(4):327–334.
  • Onofriescu M, Hogas S, Voroneanu L, et al. Bioimpedance-guided fluid management in maintenance hemodialysis: a pilot randomized controlled trial. Am J Kidney Dis. 2014;64(1):111–118.
  • Hur E, Usta M, Toz H, et al. Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial. Am J Kidney Dis. 2013;61(6):957–965.
  • Onofriescu M, Mardare NG, Segall L, et al. Randomized trial of bioelectrical impedance analysis versus clinical criteria for guiding ultrafiltration in hemodialysis patients: effects on blood pressure, hydration status, and arterial stiffness. Int Urol Nephrol. 2012;44(2):583–591.
  • Dekker MJ, Marcelli D, Canaud BJ, et al. Impact of fluid status and inflammation and their interaction on survival: a study in an international hemodialysis patient cohort. Kidney Int. 2017;91(5):1214–1223.
  • Beaubien-Souligny W, Kontar L, Blum D, et al. Meta-analysis of randomized controlled trials using tool-assisted target weight adjustments in chronic dialysis patients. Kidney Int Rep. 2019;4(10):1426–1434.
  • Scotland G, Cruickshank M, Jacobsen E, et al. Multiple-frequency bioimpedance devices for fluid management in people with chronic kidney disease receiving dialysis: a systematic review and economic evaluation. Health Technol Assess. 2018;22(1):1–138.
  • Covic A, Ciumanghel AI, Siriopol D, et al. Value of bioimpedance analysis estimated “dry weight” in maintenance dialysis patients: a systematic review and meta-analysis. Int Urol Nephrol. 2017;49(12):2231–2245.
  • US Renal Data System. Comorbid conditions and correlations with mortality risk among 3399 incident hemodialysis patients. Am J Kidney Dis. 1992;20(5 Suppl 2):32–38.
  • Wang AY, Wang M, Woo J, et al. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol. 2004;15(8):2186–2194.
  • Tang WH. B-type natriuretic peptide: a critical review. Congest Heart Fail. 2007;13(1):48–52.
  • Harrison TG, Shukalek CB, Hemmelgarn BR, et al. Association of NT-proBNP and BNP with future clinical outcomes in patients with ESKD: a systematic review and meta-analysis. Am J Kidney Dis. 2020;76(2):233–247.
  • Cao Z, Jia Y, Zhu B. BNP and NT-proBNP as diagnostic biomarkers for cardiac dysfunction in both clinical and forensic medicine. IJMS. 2019;20(8):1820.
  • Avramovski P, Janakievska P, Sotiroski K, et al. Aortic pulse wave velocity is a strong predictor of all–cause and cardiovascular mortality in chronic dialysis patients. Ren Fail. 2014;36(2):176–186.
  • Zheng D, Cheng LT, Zhuang Z, et al. Correlation between pulse wave velocity and fluid distribution in hemodialysis patients. Blood Purif. 2009;27(3):248–252.
  • Blacher J, Guerin AP, Pannier B, et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99(18):2434–2439.
  • Shinohara K, Shoji T, Tsujimoto Y, et al. Arterial stiffness in predialysis patients with uremia. Kidney Int. 2004;65(3):936–943.
  • Verbeke F, Van Biesen W, Honkanen E, et al. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol. 2011;6(1):153–159.
  • Kocyigit I, Sipahioglu MH, Orscelik O, et al. The association between arterial stiffness and fluid status in peritoneal dialysis patients. Perit Dial Int. 2014;34(7):781–790.